Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Blaney

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of Pediatric Hematology/Oncology|December 29, 2000
Phase II trial of pyrazoloacridine in children with solid tumors: a Pediatric Oncology Group phase II studyS L Berg, S M Blaney, J Sullivan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Intrathecal administration of topotecan in nonhuman primatesS M Blaney, D E Cole, K Godwin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Effect of body position on ventricular CSF methotrexate concentration following intralumbar administrationS M Blaney, D G Poplack, K Godwin, et al.
Cancer Research|June 15, 1992
Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridineS M Blaney, F M Balis, J Grem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Pharmacokinetics and cerebrospinal fluid penetration of CI-994 (N-acetyldinaline) in the nonhuman primateL Riva, S M Blaney, R Dauser, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administrationF M Balis, S M Blaney, C L McCully, et al.
Biochemical Pharmacology|April 6, 1993
Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblastsS M Blaney, J L Grem, F M Balis, et al.
Cancer Chemotherapy and Pharmacology|April 1, 1999
Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primatesB M Serabe, D J Murry, R Dauser, et al.
Cancer Chemotherapy and Pharmacology|April 29, 1998
Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primatesS M Blaney, C Takimoto, D J Murry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancersS L Berg, S M Blaney, P C Adamson, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Pediatric Hematology/Oncology|December 29, 2000
Phase II trial of pyrazoloacridine in children with solid tumors: a Pediatric Oncology Group phase II studyS L Berg, S M Blaney, J Sullivan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Intrathecal administration of topotecan in nonhuman primatesS M Blaney, D E Cole, K Godwin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Effect of body position on ventricular CSF methotrexate concentration following intralumbar administrationS M Blaney, D G Poplack, K Godwin, et al.
Cancer Research|June 15, 1992
Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridineS M Blaney, F M Balis, J Grem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Pharmacokinetics and cerebrospinal fluid penetration of CI-994 (N-acetyldinaline) in the nonhuman primateL Riva, S M Blaney, R Dauser, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administrationF M Balis, S M Blaney, C L McCully, et al.
Biochemical Pharmacology|April 6, 1993
Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblastsS M Blaney, J L Grem, F M Balis, et al.
Cancer Chemotherapy and Pharmacology|April 1, 1999
Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primatesB M Serabe, D J Murry, R Dauser, et al.
Cancer Chemotherapy and Pharmacology|April 29, 1998
Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primatesS M Blaney, C Takimoto, D J Murry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancersS L Berg, S M Blaney, P C Adamson, et al.
Pageof 5